Abstract
Lithium is an established treatment for affective disorders with good evidence of antisuicidal properties. Alzheimer's disease rates are relatively reduced in patients with bipolar disorder on lithium and a recent trial of lithium in amnestic minimal cognitive impairment is indicative of potential benefits. This should stimulate further, larger-scale studies.
Original language | English |
---|---|
Article number | N/A |
Pages (from-to) | 336-337 |
Number of pages | 2 |
Journal | British Journal of Psychiatry |
Volume | 198 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2011 |
Keywords
- ALZHEIMERS-DISEASE
- BIPOLAR DISORDER
- RISK
- MONOTHERAPY